275 related articles for article (PubMed ID: 7705699)
21. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
[TBL] [Abstract][Full Text] [Related]
23. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
24. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
25. Study of superficially invasive carcinoma of the cervix.
Simon NL; Gore H; Shingleton HM; Soong SJ; Orr JW; Hatch KD
Obstet Gynecol; 1986 Jul; 68(1):19-24. PubMed ID: 3725254
[TBL] [Abstract][Full Text] [Related]
26. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
27. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
28. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix.
Roman LD; Felix JC; Muderspach LI; Varkey T; Burnett AF; Qian D; Morrow CP
Gynecol Oncol; 1998 Mar; 68(3):220-5. PubMed ID: 9570969
[TBL] [Abstract][Full Text] [Related]
29. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer.
Steed H; Rosen B; Murphy J; Laframboise S; De Petrillo D; Covens A
Gynecol Oncol; 2004 Jun; 93(3):588-93. PubMed ID: 15196849
[TBL] [Abstract][Full Text] [Related]
30. Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri.
Alvarez RD; Gelder MS; Gore H; Soong SJ; Partridge EE
Surg Gynecol Obstet; 1993 Jun; 176(6):539-42. PubMed ID: 8322125
[TBL] [Abstract][Full Text] [Related]
31. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
[TBL] [Abstract][Full Text] [Related]
32. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
[TBL] [Abstract][Full Text] [Related]
34. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
[TBL] [Abstract][Full Text] [Related]
35. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.
Coleman RL; Keeney ED; Freedman RS; Burke TW; Eifel PJ; Rutledge FN
Gynecol Oncol; 1994 Oct; 55(1):29-35. PubMed ID: 7959262
[TBL] [Abstract][Full Text] [Related]
36. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
37. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
38. Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience.
Ramirez PT; Slomovitz BM; Soliman PT; Coleman RL; Levenback C
Gynecol Oncol; 2006 Aug; 102(2):252-5. PubMed ID: 16472844
[TBL] [Abstract][Full Text] [Related]
39. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
40. Blood transfusion and the risk of recurrence in stage IB cervical cancer.
Morris PC; Haugen J; Tomjack J; Anderson B; Buller RE
Gynecol Oncol; 1995 Jun; 57(3):401-6. PubMed ID: 7774845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]